Soft Tissue Regeneration Garners $5,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fe3b23b4-a7ee-4ecd-8eb9-5daa30fa8105
Date
1/6/2014
Company Name
Soft Tissue Regeneration
Mailing Address
142 Temple Street New Haven, CT 06510
Company Description
Soft Tissue Regeneration has developed and preliminarily tested a potential breakthrough technology for soft tissue regeneration of the anterior cruciate ligament of the knee.
Website
http://www.softtissueregeneration.com
Transaction Type
Venture Equity
Transaction Amount
$5,000,000
Transaction Round
Undisclosed
Proceeds Purposes
The $5 million financing commitment will permit STR to complete its European Phase I clinical study and continue the FDA regulatory process for the Company’s L-C Ligament®, a bioresorbable, implantable scaffold for the repair and regeneration of an injured or torn anterior cruciate ligament (“ACL”).
M&A Terms
Venture Investor
Connecticut Innovations
Venture Investor
LaunchCapital
Venture Investor
The Vertical Group